Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIDOT phase 3 study of venglustat for neuropathic pain and abdominal pain in Fabry disease
CTR20220858Phase 3Active
- Sponsor
- Sanofi
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venglustat in Fabry disease (FD), sponsored by Sanofi. Started Aug 2022; status: active.
02
Drugs
venglustat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on CTR20220858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220858.